Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 19

1.

Using induced pluripotent stem cells derived neurons to model brain diseases.

McKinney CE.

Neural Regen Res. 2017 Jul;12(7):1062-1067. doi: 10.4103/1673-5374.211180. Review.

2.

Exosomes: Origins and Therapeutic Potential for Neurodegenerative Disease.

Sarko DK, McKinney CE.

Front Neurosci. 2017 Feb 27;11:82. doi: 10.3389/fnins.2017.00082. eCollection 2017. Review.

3.
4.

Hypertrophy, increased ejection fraction, and reduced Na-K-ATPase activity in phospholemman-deficient mice.

Jia LG, Donnet C, Bogaev RC, Blatt RJ, McKinney CE, Day KH, Berr SS, Jones LR, Moorman JR, Sweadner KJ, Tucker AL.

Am J Physiol Heart Circ Physiol. 2005 Apr;288(4):H1982-8. Epub 2004 Nov 24.

5.

Polymorphism and evolution in the constant region of the T-cell receptor beta chain in an advanced teleost fish.

Kamper SM, McKinney CE.

Immunogenetics. 2002 Mar;53(12):1047-54. Epub 2002 Feb 7.

PMID:
11904682
6.

Glucosylsphingosine accumulation in mice and patients with type 2 Gaucher disease begins early in gestation.

Orvisky E, Sidransky E, McKinney CE, Lamarca ME, Samimi R, Krasnewich D, Martin BM, Ginns EI.

Pediatr Res. 2000 Aug;48(2):233-7.

PMID:
10926300
7.

Mice with an aspartylglucosaminuria mutation similar to humans replicate the pathophysiology in patients.

Jalanko A, Tenhunen K, McKinney CE, LaMarca ME, Rapola J, Autti T, Joensuu R, Manninen T, Sipilä I, Ikonen S, Riekkinen P Jr, Ginns EI, Peltonen L.

Hum Mol Genet. 1998 Feb;7(2):265-72.

PMID:
9425233
8.

Mice that lack thrombospondin 2 display connective tissue abnormalities that are associated with disordered collagen fibrillogenesis, an increased vascular density, and a bleeding diathesis.

Kyriakides TR, Zhu YH, Smith LT, Bain SD, Yang Z, Lin MT, Danielson KG, Iozzo RV, LaMarca M, McKinney CE, Ginns EI, Bornstein P.

J Cell Biol. 1998 Jan 26;140(2):419-30.

9.

Metaxin, a gene contiguous to both thrombospondin 3 and glucocerebrosidase, is required for embryonic development in the mouse: implications for Gaucher disease.

Bornstein P, McKinney CE, LaMarca ME, Winfield S, Shingu T, Devarayalu S, Vos HL, Ginns EI.

Proc Natl Acad Sci U S A. 1995 May 9;92(10):4547-51.

10.

Consequences of beta-glucocerebrosidase deficiency in epidermis. Ultrastructure and permeability barrier alterations in Gaucher disease.

Holleran WM, Ginns EI, Menon GK, Grundmann JU, Fartasch M, McKinney CE, Elias PM, Sidransky E.

J Clin Invest. 1994 Apr;93(4):1756-64.

11.

Human CYP1A1 gene: cosegregation of the enzyme inducibility phenotype and an RFLP.

Petersen DD, McKinney CE, Ikeya K, Smith HH, Bale AE, McBride OW, Nebert DW.

Am J Hum Genet. 1991 Apr;48(4):720-5.

14.
15.

Aryl hydrocarbon hydroxylase inducibility among primary relatives of children with leukemia or solid tumors.

Levine AS, McKinney CE, Echelberger CK, Kouri RE, Edwards BK, Nebert DW.

Cancer Res. 1984 Jan;44(1):358-62.

16.

Variations in aryl hydrocarbon hydroxylase activities in mitogen-activated human and nonhuman primate lymphocytes.

Kouri RE, McKinney CE, Levine AS, Edwards BK, Vesell ES, Nebert DW, McLemore TL.

Toxicol Pathol. 1984;12(1):44-8.

PMID:
6093229
17.

Positive correlation between high aryl hydrocarbon hydroxylase activity and primary lung cancer as analyzed in cryopreserved lymphocytes.

Kouri RE, McKinney CE, Slomiany DJ, Snodgrass DR, Wray NP, McLemore TL.

Cancer Res. 1982 Dec;42(12):5030-7.

18.

A method for detecting aryl hydrocarbon hydroxylase activities in cryopreserved human lymphocytes.

Kouri RE, Oberdorf J, Slomiany DJ, McKinney CE.

Cancer Lett. 1981 Oct;14(1):29-40.

PMID:
7296539
19.

Parameters influencing quantitation of 3-methylcholanthrene-induced aryl hydrocarbon hydroxylase activity in cultured human lymphocytes.

Kouri RE, Imblum RL, Sosnowski RG, Slomiany DJ, McKinney CE.

J Environ Pathol Toxicol. 1979 Mar-Apr;2(4):1079-98. No abstract available.

PMID:
109558

Supplemental Content

Loading ...
Support Center